Nonsmall Cell Lung Carcinoma with Giant Cell Features Expressing Programmed Death-Ligand 1: A Report of a Patient Successfully Treated with Pembrolizumab

Giant cell carcinoma, a rare variant of nonsmall cell lung carcinoma (NSCLC), is characterized by aggressive progression and poor response to conventional chemotherapy. This report is the first to describe a patient with NSCLC and giant cell features who was successfully treated with pembrolizumab,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Case Rep Oncol Med
Asıl Yazarlar: Nakayama, Shingo, Sasaki, Mamoru, Morinaga, Shojiroh, Minematsu, Naoto
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2018
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5875061/
https://ncbi.nlm.nih.gov/pubmed/29736285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5863015
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller